Devices, digital health, and the technology changing how care is delivered.
Dexcom, Abbott, MiniMed and Insulet featured upcoming technologies at the American Diabetes Association’s annual event. Catch up on news coming out of the conference.
The stroke treatment could contribute about $100 million in incremental revenue over time to Boston Scientific, the buyer of Penumbra, one analyst said.
Winning in health-tech is about giving buyers enough operational clarity, early enough, that they can say yes with confidence rather than saying yes because the alternative is another six months of the same evaluation cycle. The post Stop Presenting at Health-Tech Buyers — Let Them Drive appeared first on MedCity News .
Insecurity about transportation can lead to missed appointments and delayed care, and obstacles are more common for cancer patients than for the general population. The post Reliable Transportation Isn’t a Luxury — It’s an Important Part of Cancer Care appeared first on MedCity News .
Bright overhead lighting, constant alarms, hard surfaces, and abrupt transitions between spaces can trigger agitation, confusion, and sensory overload. These reactions are not incidental; they directly affect recovery, staff workload, and cost. The post Designing Care Environments for Sensory Regulation, Not Just Clinical Efficiency appeared first on MedCity News .
Clinical AI startup Abridge held a New York City event to signal it’s done being thought of as just an AI scribe. The company announced a Nvidia foundation model partnership, an Eli Lilly investment, new capabilities for its platform, and the intent to help mediate the relationship between payers and providers. The post Abridge Goes Beyond Documentation: 4 Updates appeared first on MedCity News .
Novartis said its RNA therapy del-brax met goals of a Phase 1/2 study in facioscapulohumeral muscular dystrophy (FSHD), an inherited muscle disorder that currently has no FDA-approved medicines. Del-brax is one of three RNA therapies from Novartis’s $12 billion acquisition of Avidity Biosciences. The post Novartis RNA Med From $12B Deal Keeps Building Case to Become First Therapy for Rare Muscle Disease appeared first on MedCity News .
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes Care.
The next phase of AI in healthcare is about building systems where human clinicians, supervisors, and AI can all contribute, challenge each other, and improve how decisions are made. The post From Copilots to Clinical Judgment: The Next Phase of AI in Digital Behavioral Health appeared first on MedCity News .
AI is not driving healthcare cost inflation. It is exposing a system that has always been designed to reward it, and making that system more efficient. As long as reimbursement is tied to intensity, every technological advancement will move in the same direction: toward maximizing it. The post AI Is Scaling Healthcare Costs Because the System Was Built That Way appeared first on MedCity News .
EHR switching involves risk. But taking a life cycle view, considering data migration, workflow configuration, training, downtime, ongoing fees and eventual exit terms, can put an end to your EHR pain. The post What Healthcare Leaders Get Wrong About EHR Switching appeared first on MedCity News .
CEO Rainer Blair said Danaher has the money and “leadership bandwidth” to strike further deals across any of its three business areas.
The Digital Medicine Society launched an initiative to help payers and virtual care providers avoid common contract implementation challenges. The post DiMe Launches New Initiative for Virtual-First Care appeared first on MedCity News .
Parabilis Medicines is developing a new type of peptide drug capable of hitting elusive disease targets inside cells. Cancer is the biotech’s initial focus, and the IPO cash will support lead program zolucatetide, which is in development for a rare type of tumor with limited treatment options. The post Parabilis Medicines’ Quest to Drug the Undruggable Picks Up $745M From Upsized IPO appeared first on MedCity News .
The company plans to eliminate 119 positions by mid-December as part of a phased transfer of some production from the manufacturing site.
The next evolution of patient experience will not be defined by more digital touchpoints. It will be defined by giving nurses and care teams the capacity to be fully present. The post Restoring the Patient-Clinician Relationship to the Center of Care appeared first on MedCity News .
Prevention requires more than faster detection. Organizations need payment programs with end-to-end visibility and controls that intervene before losses occur. The post From Detection to Defense: Building Fraud-Resilient Healthcare Payment Systems appeared first on MedCity News .
[Sponsored] Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs. The post The Healthcare Payments Industry Has a Perception Problem appeared first on MedCity News .
Healthcare needs systems that work for providers, for health plans, and most importantly, for patients. And that starts with designing not just for technology, but for the people who depend on it, people who need to trust it will work when it matters most. The post Healthcare IT Isn’t Broken — But How We Design It Might Be appeared first on MedCity News .
[Sponsored] Our new report will focus on how people who work for payers are thinking about AI and cybersecurity needs to protect sensitive healthcare data. The post Take Part in Our Survey on Healthcare AI and Security appeared first on MedCity News .
Introduction Adult-onset type 1 diabetes (T1D) is often misclassified as type 2 diabetes (T2D), resulting in delayed treatment, missed opportunities for referrals to specialists and increased risk of complications including diabetic ketoacidosis. An electronic medical record (EMR)-based algorithm—originally trained on a large national EMR dataset to identify likely misclassified adult-onset T1D cases—was tested and retrained on a health information exchange (HIE) dataset from HealthShare Exchange (HSX). Promising results were achieved on historical data, particularly when using the retrained…
This survey study investigates national trends in wearable device use and data sharing with clinicians among US adults from 2020 to 2024.
Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in developing automated insulin delivery systems that don’t require meal announcements.
With the CE mark for ear, nose and throat procedures, the advanced surgical navigation platform will be available to more surgeons across the region.